Re: Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al. Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer. Eur Urol. 2023;83:313-7.

作者信息

Cheng Chunliang, Hu Jiao, Chen Jinbo

机构信息

Department of Urology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, PR China.

出版信息

Eur Urol. 2023 Jun;83(6):e159-e160. doi: 10.1016/j.eururo.2023.02.029. Epub 2023 Mar 25.

DOI:10.1016/j.eururo.2023.02.029

PMID:36967357

Abstract

摘要

相似文献

Re: Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al. Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer. Eur Urol. 2023;83:313-7.

Eur Urol. 2023 Jun;83(6):e159-e160. doi: 10.1016/j.eururo.2023.02.029. Epub 2023 Mar 25.

Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014.回复：弗洛里斯·H·格罗嫩迪克、杰罗恩·德容、伊丽莎白·E·弗兰森·范德普特等。ERBB2突变特征为一组对新辅助化疗有极佳反应的肌层浸润性膀胱癌。《欧洲泌尿外科杂志》。即将发表。http://dx.doi.org/10.1016/j.eururo.2015.01.014 。

Eur Urol. 2015 Aug;68(2):e31-2. doi: 10.1016/j.eururo.2015.02.044. Epub 2015 Mar 12.

Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014.回复埃利泽·M·范·艾伦、利瓦伊·A·加拉韦和乔纳森·E·罗森伯格致编辑的信，信的内容涉及弗洛里斯·H·格罗嫩迪克、杰罗恩·德容、伊丽莎白·E·弗兰森·范·德·普特等人的文章：《ERBB2突变特征定义了一组对新辅助化疗有良好反应的肌层浸润性膀胱癌》。《欧洲泌尿外科杂志》即将发表。http://dx.doi.org/10.1016/j.eururo.2015.01.014 。

Eur Urol. 2015 Aug;68(2):e33-4. doi: 10.1016/j.eururo.2015.02.043. Epub 2015 Mar 13.

Re: J. Alberto Nakauma-González, Maud Rijnders, Job van Riet, et al. Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma. Eur Urol 2022;81:331-6: Novel Insights into Evidence of Metastatic Urothelial Carcinoma Transcriptomic Subtype.回复：J. 阿尔韦托·中马-冈萨雷斯、莫德·林德斯、乔布·范·里特等。综合分子特征揭示转移性尿路上皮癌的基因组和转录组亚型。《欧洲泌尿外科杂志》2022年；81卷：331 - 336页：转移性尿路上皮癌转录组亚型证据的新见解。

Eur Urol. 2022 Sep;82(3):e76-e77. doi: 10.1016/j.eururo.2022.05.026. Epub 2022 Jun 14.

Re: Bernadett Szabados, Mark Kockx, Zoe June Assaf, et al. Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder. Eur Urol 2022;82:212-22.回复：贝尔纳黛特·绍巴多斯、马克·科克斯、佐伊·琼·阿萨夫等。阿替利珠单抗新辅助治疗不适用于顺铂的膀胱肌层浸润性尿路上皮癌患者的最终结果。《欧洲泌尿外科杂志》2022年；82卷：212 - 22页

Eur Urol. 2022 Dec;82(6):e176. doi: 10.1016/j.eururo.2022.08.037. Epub 2022 Oct 1.

Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer.DNA修复基因缺陷可预测肌层浸润性膀胱癌对基于顺铂的新辅助化疗的反应。

Eur Urol. 2015 Dec;68(6):959-67. doi: 10.1016/j.eururo.2015.07.009. Epub 2015 Aug 1.

Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy.原发性和继发性肌层浸润性膀胱癌之间的基因组差异是基于顺铂为基础的新辅助化疗疗效差异的基础。

Eur Urol. 2019 Feb;75(2):231-239. doi: 10.1016/j.eururo.2018.09.002. Epub 2018 Oct 2.

Reply to Yuxuan Song, Caipeng Qin, and Tao Xu's Letter to the Editor re: J. Alberto Nakauma-González, Maud Rijnders, Job van Riet, et al. Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma. Eur Urol 2022;81:331-6.对宋宇轩、秦彩鹏和徐涛致编辑的信的回复，信的主题为：J. 阿尔韦托·中马-冈萨雷斯、莫德·林德斯、乔布·范·里特等人的《综合分子特征揭示转移性尿路上皮癌的基因组和转录组亚型》。《欧洲泌尿外科杂志》2022年；81卷：331 - 336页。

Eur Urol. 2022 Sep;82(3):e78-e79. doi: 10.1016/j.eururo.2022.05.027. Epub 2022 Jun 16.

Re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer?回复：白云锦、杨玉波和唐寅致编辑的信，主题为：安德里亚·内奇、马尔科·班迪尼、朱塞平娜·卡莱雷索等人。多参数磁共振成像作为肌肉浸润性膀胱癌新辅助派姆单抗治疗肿瘤反应的无创评估：PURE - 01研究的初步结果。《欧洲泌尿外科杂志》2020年；77卷：636 - 43页。《欧洲泌尿外科杂志》2020年；77卷：e158：多参数磁共振成像能否取代传统的经尿道膀胱癌切除术？

Eur Urol. 2021 Jan;79(1):e35-e36. doi: 10.1016/j.eururo.2020.08.006. Epub 2020 Aug 20.

Re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7.: Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?回复：戈特弗里德·舍达尔、约翰·亚伯拉罕松、卡琳·霍尔姆斯特伦等。尿路上皮癌分子亚型对新辅助化疗的不同反应。《欧洲泌尿外科杂志》。2022年；81卷：316 - 317页：肌层浸润性膀胱癌的新辅助化疗反应：内在生物学差异还是亚型命名差异？

Eur Urol. 2022 Apr;81(4):e90-e91. doi: 10.1016/j.eururo.2021.12.033. Epub 2022 Jan 14.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验